ID: h-495e04396a
Hypothesis
Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propagation
Enteric α-synuclein misfolding spreads retrogradely via vagal afferents to DMV, then progressively to SNc (Braak stages III-VI).
EvidencePending (0%)📖 0 cit🗣 3 debates✓ 12 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
Enteric α-synuclein misfolding spreads retrogradely via vagal afferents to DMV, then progressively to SNc (Braak stages III-VI). While anatomically compelling, the central assumption that enteric pathology is the initiating event is contested. Overexpression artifacts dominate animal models; vagotomy protection is inconsistently replicated. Best therapeutic strategy: transcutaneous vagus nerve stimulation (t-VNS) for desynchronization rather than blocking physical propagation.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["SNCA Alpha-Synuclein<br/>Presynaptic Protein"]
B["SNCA Misfolding<br/>Environmental Stress"]
C["SNCA Oligomers<br/>Toxic Protofibrils"]
D["Mitochondrial Pore<br/>Membrane Disruption"]
E["Lewy Body Formation<br/>Cytoplasmic Inclusions"]
F["Dopaminergic Neuron<br/>Dysfunction/Death"]
G["Nigrostriatal Degeneration<br/>Motor Symptoms"]
H["SNCA A53T/A30P/E46K<br/>Familial PD Mutations"]
A --> B
B --> C
C --> D
C --> E
D --> F
E --> F
F --> G
H -.->|"accelerates"| B
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style H fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8⚖️ Evidence
⚖️ Evidence Matrix6 supports2 contradicts
Supports
Movement of prion-like α-synuclein along the gut-brain axis in Parkinson's disease.
2021PMID:34043864
Supports
Intrastriatal injection of Parkinson's disease intestine and vagus lysates initiates pathology.
2024PMID:36604420
Supports
The Neural Gut-Brain Axis of Pathological Protein Aggregation in Parkinson's Disease.
2021PMID:34372600
Supports
Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation pathways.
2019PMID:31254094
Supports
Accumulation of prion protein in the vagus nerve in Creutzfeldt-Jakob disease — comparative evidence for vagal highway.
2019PMID:30801763
Contradicts
Vagotomy studies show inconsistent results across populations — some show reduced PD risk after truncal vagotomy, others find no association.
Contradicts
Prion-like hypothesis for α-syn still contested — alternative mechanisms include shared genetic background, microbiome metabolites, and systemic inflammation.
📖 Linked Papers (6)Export BibTeX ↗
The Gut-Brain Axis Based on α-Synuclein Propagation-Clinical, Neuropathological, and Experimental Evidence.
International journal of molecular sciences (2025) · PubMed:40362234 ↗
3 figures
Figure 1
Lewy bodies (LBs) and a pale body. ( a ) An LB and ( b ) a pale body in a dopamine neuron in the substantia nigra. ( c ) An LB in the dorsal motor nucleus of th...
Figure 2
Prion-like propagation of aSyn pathology in PD. (Upper panel) Misfolded aSyn works as a seed, convert wild-type aSyn into an abnormal conformation, and amplify ...
Lewy Body Disease Primate Model with α-Synuclein Propagation from the Olfactory Bulb.
Mov Disord (2022) · PubMed:35989519 ↗
No figures
Movement of prion-like α-synuclein along the gut-brain axis in Parkinson's disease: A potential target of curcumin treatment.
The European journal of neuroscience (2021) · PubMed:34043864 ↗
No figures
Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury.
Acta Neuropathol Commun (2015) · PubMed:25853980 ↗
No figures
🏥 Translation
🧬 3D Protein Structure — SNCA
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for SNCA/p-SNCA (Ser129)/GBA/LRRK2 from GTEx v10.
💉 Clinical Trials (5)Relevance: 58%
0
Active
Active
0
Completed
Completed
0
Total Enrolled
Total Enrolled
NA
Highest Phase
Highest Phase
ACTIVE_NOT_RECRUITING·NCT04553185 · University of Exeter
Parkinson Disease
Study procedure
RECRUITING·NCT02305147 · Institut National de la Santé Et de la Recherche Médicale, France
Parkinson Disease
Clinical, biological and imaging followup
ENROLLING_BY_INVITATION·NCT04701177 · Greece 2021 Committee
Presymptomatic Disease Mild Cognitive Impairment Memory Loss (Excluding Dementia)
Teleph0s digital phenotyping platform
RECRUITING·NCT04477785 · Michael J. Fox Foundation for Parkinson's Research
Parkinson Disease
COMPLETED·NCT04557865 · National Taiwan University Hospital
Tau Distributions in Patients With Tauopathy Using APN-1607 PET Scan
18F-PMPBB3 (APN-1607) PET imaging
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for SNCA.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.6%
Volatility
Medium
0.0483
Events (7d)
3
Price History
▼3.6%💾 Resource Usage
API Calls
3
Total Cost
$0.0000
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF enteric α-synuclein pathology (phosphorylated Ser129 aggregates) is experimentally seeded in the gastric wall of non-human primates followed by comprehensive neuropathological assessment at 18 mont | p-SNCA aggregates present in DMV with confirmed vagal axonal transport markers (NFL, phosphorylated neurofilament), quantified as ≥15 aggregates per DMV section | — no observation — | pending | 0.40 |
| IF early-stage Parkinson's disease patients (Hoehn-Yahr stage 1-2) receive transcutaneous vagus nerve stimulation (t-VNS, 25 Hz, 30 min daily) for 12 months, THEN their longitudinal DAT-scan binding r | DAT-scan binding ratio decline ≤15% in t-VNS group vs. ≥30% in sham group over 12 months, with corresponding slower MDS-UPDRS Part III progression | — no observation — | pending | 0.35 |
🔮 Falsifiable Predictions (2)
pendingconf 40%
IF enteric α-synuclein pathology (phosphorylated Ser129 aggregates) is experimentally seeded in the gastric wall of non-human primates followed by comprehensive neuropathological assessment at 18 months post-inoculation, THEN p-SNCA aggregates will be detectable in the dorsal motor nucleus of the va
Predicted outcome: p-SNCA aggregates present in DMV with confirmed vagal axonal transport markers (NFL, phosphorylated neurofilament), quantified as ≥15 aggregates per D
Falsification: If p-SNCA aggregates are absent in DMV despite verified gastric seeding (confirmed by immunohistochemistry and ELISA) in >50% of animals at 18 months, the retrograde vagal propagation hypothesis is fa
pendingconf 35%
IF early-stage Parkinson's disease patients (Hoehn-Yahr stage 1-2) receive transcutaneous vagus nerve stimulation (t-VNS, 25 Hz, 30 min daily) for 12 months, THEN their longitudinal DAT-scan binding ratios in the caudate/putamen will decline by ≤15% compared to sham controls, indicating slowed dopam
Predicted outcome: DAT-scan binding ratio decline ≤15% in t-VNS group vs. ≥30% in sham group over 12 months, with corresponding slower MDS-UPDRS Part III progression
Falsification: If t-VNS-treated patients show identical or greater dopaminergic degeneration (≥30% binding decline) and motor progression compared to sham controls, the desynchronization therapeutic hypothesis is fa
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
1
Incoming
0
Outgoing
0
0 supporting
0 contradicting
1 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.